# Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

> **NCT01587469** · — · COMPLETED · sponsor: **Cepheid** · enrollment: 992 (actual)

## Conditions studied

- Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01587469
- **Lead sponsor:** Cepheid
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-02-21
- **Final completion:** 2014-02-21
- **Target enrollment:** 992 (ACTUAL)
- **Last updated:** 2018-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587469, "Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01587469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*